TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CLINIGEN HLTHCARE

ImmunologyInfectious Disease
Specialty

CLINIGEN HLTHCARE is a specialty pharmaceutical company focused on Immunology, Infectious Disease.

1991
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%
1 drugs
Infectious Disease 50%
1 drugs

Pipeline Strength Pro

Loading...